top of page
Nov 20

New Wave Biotech launches Bioprocess Foresight to help biomanufacturing innovators design smarter, commercialise quicker and scale greener

AI bioprocess simulation platform empowers biomanufacturers to make better decisions and processing tech companies to accelerate sales and R&D


Historical experimental data can now be harnessed alongside current data to accelerate future R&D

 London, 20th November 2024 - AI bioprocess simulation software company New Wave Biotech is helping alt protein and biomanufacturing companies design better, commercialise quicker and scale greener through new technology launched today. 


The Bioprocess Foresight platform harnesses AI-powered simulation to give biomanufacturing innovators a clear picture of techno-economics, output and environmental impact, tailored to their process with their data. Not only does the solution provide users with a holistic view of their process, it provides actionable insights to identify R&D hotspots, and the ability to virtually test unlimited possibilities to understand the likely outcome. 


According to BCG, a third of global manufacturing can be produced with synthetic biology by 2030, replacing unsustainable animal and petrochemical products, yet 90% of these technologies fail to scale. This is because optimisation is hard - there are over one trillion possible combinations of processes, the average cost for conducting an experiment ranges between $10k-100k, and scaling from lab to market takes between 3-10 years. Cost insight is also slow and expensive - the cost of just one Techno Economic Analysis (TEA) report ranges between $20k - 40k and takes months to complete. 


NWB’s Bioprocess Foresight platform simulates bioprocesses to predict quantified output, costs and sustainability impact and improves as it learns from empirical-data. This transforms how biomanufacturing R&D is done:


  • Faster: Automated techno-economic calculations in hours not months.

  • Cheaper: Understand your projected output, economics and sustainability from £83/month, rather than $20-40k per report.

  • Smarter: Get a full picture of your process across commercial, technical and environmental areas, tailored to your process using your data.

  • Actionable: Navigate trillions of interrelated options with analysis and visualisation tools and test scenarios by changing technical, market and production variables.

  • Easier: Intuitive design for innovators from all backgrounds.


This enables:


  • Biomanufacturing innovators to make better decisions to accelerate R&D and commercialisation.

  • Corporates to leverage historical experimental data to power future R&D.

  • Processing technology companies to accelerate sales and R&D enabling customers to virtually test their technology and see the impact on their bottom line.


Zoe Law, CEO and Co-Founder at New Wave Biotech commented: “For too long biomanufacturing innovators have been paying hundreds of thousands for R&D and thousands more just to understand where past experiments have failed. Now imagine if you're developing a new bioproduct and can virtually test any process to predict its techno economics and sustainability when it scales. This gives you the foresight with quantified impact that you need for strategic decision making.”


Oli Hall, CTO and Co-Founder at New Wave Biotech concluded: “Biomanufacturing businesses today have to navigate a landscape of thousands of potential options so need to be able to make explainable predictions of technical, commercial and environmental impact and optimise accordingly. That’s why our bioprocess simulation platform is designed to enable biotech innovators to design better, commercialise quicker and scale greener.”


To try the new platform, please go to www.newwavebiotech.com 


New Wave Biotech will also be available to discuss these latest updates at the below events:

---


Media contact

Gary O’Sullivan

07817903406


Notes to editors:



About New Wave Biotech


New Wave Biotech unlocks the power of biomanufacturing for the sustainable transformation of global supply chains. Its purpose is to help biomanufacturing design smarter, commercialise quicker and scale greener by providing bioprocessing foresight for innovation. For more information, contact hello@newwavebiotech.com.

Comments

bottom of page